- Home
- NRSN vs SCNX Comparison
NRSN vs SCNX Comparison
Compare NRSN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- SCNX
- Stock Information
- Founded
- NRSN 2017
- SCNX 2010
- Country
- NRSN Israel
- SCNX United States
- Employees
- NRSN N/A
- SCNX N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- NRSN Health Care
- SCNX Health Care
- Exchange
- NRSN Nasdaq
- SCNX Nasdaq
- Market Cap
- NRSN 29.8M
- SCNX 31.5M
- IPO Year
- NRSN 2021
- SCNX 2020
- Fundamental
- Price
- NRSN $0.98
- SCNX $0.63
- Analyst Decision
- NRSN Buy
- SCNX
- Analyst Count
- NRSN 2
- SCNX 0
- Target Price
- NRSN $14.00
- SCNX N/A
- AVG Volume (30 Days)
- NRSN 202.0K
- SCNX 59.7M
- Earning Date
- NRSN 12-17-2025
- SCNX 11-13-2025
- Dividend Yield
- NRSN N/A
- SCNX N/A
- EPS Growth
- NRSN N/A
- SCNX N/A
- EPS
- NRSN N/A
- SCNX N/A
- Revenue
- NRSN N/A
- SCNX $653,391.00
- Revenue This Year
- NRSN N/A
- SCNX N/A
- Revenue Next Year
- NRSN N/A
- SCNX N/A
- P/E Ratio
- NRSN N/A
- SCNX N/A
- Revenue Growth
- NRSN N/A
- SCNX 207.88
- 52 Week Low
- NRSN $0.80
- SCNX $0.46
- 52 Week High
- NRSN $2.60
- SCNX $8.72
- Technical
- Relative Strength Index (RSI)
- NRSN 37.32
- SCNX 44.24
- Support Level
- NRSN $0.89
- SCNX $0.65
- Resistance Level
- NRSN $0.97
- SCNX $0.78
- Average True Range (ATR)
- NRSN 0.07
- SCNX 0.14
- MACD
- NRSN -0.01
- SCNX -0.02
- Stochastic Oscillator
- NRSN 26.22
- SCNX 1.95
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.